BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

TNX-4200 is a small molecule broad-spectrum antiviral agent targeting CD45 for the prevention or treatment of infections ... Zembrace and Tosymra are not for people with risk factors for heart disease ...

The cause of Behçet's syndrome is unknown but peripheral blood CD45 γδ T cells in Behçet's produce >50-fold more TNF-α than controls when stimulated with phorbol myristate acetate and anti-CD3.

Peripheral blood mononuclear cells (PBMCs ... Japan). Monocytes were defined as CD45+CD56-CD14+7-AAD- population. Conjugated monoclonal antibodies to CD45, CD56, CD14, and 7-AAD were added to the cell ...

Peripheral blood (PB), BM, lung, liver ... organs were washed once in PBS and stained with phycoerythrin-cyanin 7 (PE/Cy7)-conjugated anti-human CD45 antibody (Biolegend, 304016). Analyses were ...

CD34 and CD45 (table 1). Autologous conditioned serum was chosen as a carrier media in which to suspend the AdMSCs at time of injection. The combination of MSCs with a blood-derived carrier media has ...